mitoxantrone has been researched along with Hematologic Malignancies in 3 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Halpern, AB | 1 |
| Othus, M | 1 |
| Huebner, EM | 1 |
| Scott, BL | 1 |
| Hendrie, PC | 1 |
| Percival, MM | 1 |
| Becker, PS | 1 |
| Smith, HA | 1 |
| Oehler, VG | 1 |
| Orozco, JJ | 1 |
| Cassaday, RD | 1 |
| Gardner, KM | 1 |
| Chen, TL | 1 |
| Buckley, SA | 1 |
| Orlowski, KF | 1 |
| Anwar, A | 1 |
| Estey, EH | 1 |
| Walter, RB | 1 |
| Ozdogu, H | 1 |
| Boga, C | 1 |
| Kizilkilic, E | 1 |
| Kozanoglu, I | 1 |
| Karakus, S | 1 |
| Sahin, FI | 1 |
| Unalan, D | 1 |
| Haberal, M | 1 |
| Chow, KU | 1 |
| Boehrer, S | 1 |
| Bojunga, J | 1 |
| Stieler, M | 1 |
| Rummel, MJ | 1 |
| Fauth, F | 1 |
| Schneider, B | 1 |
| Martin, H | 1 |
| Hoelzer, D | 1 |
| Weidmann, E | 1 |
| Mitrou, PS | 1 |
1 trial available for mitoxantrone and Hematologic Malignancies
| Article | Year |
|---|---|
Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Disease-Free Survival; Fema | 2019 |
2 other studies available for mitoxantrone and Hematologic Malignancies
| Article | Year |
|---|---|
The first 2 years of clinical experience with peripheral blood stem cell transplantation for various hematological malignancies: results from a single Baskent University Center.
Topics: Adult; Aged; Antineoplastic Agents; Communicable Disease Control; Cyclosporine; Female; Hematologic | 2007 |
Induction of apoptosis by cladribine (2-CdA), gemcitabine and other chemotherapeutic drugs on CD34+/CD38+ and CD34+/CD38- hematopoietic progenitor cells: selective effects of doxorubicin and 2-CdA with protection of immature cells.
Topics: Antigens, CD34; Antineoplastic Agents; Apoptosis; Cladribine; Cyclophosphamide; Deoxycytidine; Dose- | 2002 |